Alimera Sciences Alpha and Beta Analysis
| ALIMDelisted Stock | USD 5.54 0.01 0.18% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Alimera Sciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Alimera Sciences over a specified time horizon. Remember, high Alimera Sciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Alimera Sciences' market risk premium analysis include:
Beta (0.81) | Alpha 1.3 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Alimera |
Alimera Sciences Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Alimera Sciences market risk premium is the additional return an investor will receive from holding Alimera Sciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Alimera Sciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Alimera Sciences' performance over market.| α | 1.30 | β | -0.81 |
Alimera Sciences Fundamentals Vs Peers
Comparing Alimera Sciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Alimera Sciences' direct or indirect competition across all of the common fundamentals between Alimera Sciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Alimera Sciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Alimera Sciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Alimera Sciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Alimera Sciences to competition |
| Fundamentals | Alimera Sciences | Peer Average |
| Return On Equity | -0.35 | -0.31 |
| Return On Asset | 0.0098 | -0.14 |
| Profit Margin | (0.15) % | (1.27) % |
| Operating Margin | 0.08 % | (5.51) % |
| Current Valuation | 360.44 M | 16.62 B |
| Shares Outstanding | 54.38 M | 571.82 M |
| Shares Owned By Insiders | 5.34 % | 10.09 % |
Alimera Sciences Opportunities
Alimera Sciences Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | ALIM Stock Alert Halper Sadeh LLC Is Investigating Whether the Sale of Alimera Sciences, Inc. Is Fair to Shareholders | 06/24/2024 |
2 | Investing in Alimera Sciences a year ago would have delivered you a 68 percent gain | 07/25/2024 |
3 | AnaptysBio, Inc. Reports Q2 Loss, Misses Revenue Estimates | 08/05/2024 |
4 | Alimera Sciences Reports Second Quarter 2024 Results | 08/06/2024 |
5 | Should You Invest on Alimera Sciences, Inc. Right Now | 08/09/2024 |
6 | ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences | 09/10/2024 |
7 | ANI Pharmaceuticals, Alimera Sciences deal set to close Monday | 09/11/2024 |
About Alimera Sciences Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Alimera or other delisted stocks. Alpha measures the amount that position in Alimera Sciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Alimera Sciences Upcoming Company Events
As portrayed in its financial statements, the presentation of Alimera Sciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Alimera Sciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Alimera Sciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Alimera Sciences. Please utilize our Beneish M Score to check the likelihood of Alimera Sciences' management manipulating its earnings.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 29th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Alimera Sciences
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in Alimera Stock
If you are still planning to invest in Alimera Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alimera Sciences' history and understand the potential risks before investing.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |